Elanix Biotechnologies AG (FRA:ELN) Total Assets : €1.08 Mil (As of Dec. 2018)

Elanix Biotechnologies AG Total Assets Chart

Elanix Biotechnologies AG Annual Data
	Trend	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18
Total Assets		Get a 7-Day Free Trial					0.31	22.75	21.81	2.47	1.08

Elanix Biotechnologies AG Semi-Annual Data
	Dec08	Dec09	Jun10	Dec10	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18
Total Assets	Get a 7-Day Free Trial															21.81	23.91	2.47	21.57	1.08

Elanix Biotechnologies AG Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Elanix Biotechnologies AG's Total Assets for the fiscal year that ended in Dec. 2018 is calculated as

Elanix Biotechnologies AG's Total Assets for the quarter that ended in Dec. 2018 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elanix Biotechnologies AG  (FRA:ELN) Total Assets Explanation

Total Assets is connected with ROA %.

Elanix Biotechnologies AG's annualized ROA % for the quarter that ended in Dec. 2018 is

Note: The Net Income data used here is two times the semi-annual (Dec. 2018) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Elanix Biotechnologies AG's Asset Turnover for the quarter that ended in Dec. 2018 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Elanix Biotechnologies AG Total Assets Related Terms

Thank you for viewing the detailed overview of Elanix Biotechnologies AG's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Elanix Biotechnologies AG (FRA:ELN) Business Description